Table 2.
Population characteristics according to their vaccination status.
| Vaccination status | Unvaccinated | Incomplete Vaccination |
Fully Vaccinated |
|---|---|---|---|
| N | 2619 | 636 | 520 |
| Age: | |||
| Median (IQR) | 26 (20-34) | 26 (21–35) | 32 (24–46) |
| Mean (SD) | 27.3 (12.9) | 29.6 (11.6) | 36.0 (14.5) |
| Male: N (%) | 1349 (51.5%) | 322 (50.6%) | 261 (50.2%) |
| Symptomatic patients: N (%) | |||
| -No | 1021 (39.0%) | 187 (29.4%) | 208 (40%) |
| -Yes | 1598 (61.0%) | 449 (70.6%) | 312 (60%) |
| Symptom onset/diagnosis time, N (%) | |||
| -1 day | 497 (31.1%) | 145 (32.3%) | 109 (34.9%) |
| -2–4 days | 759 (47.5%) | 227 (50.6%) | 153 (49.0%) |
| -5–7 days | 267 (16.7%) | 72 (16.0%) | 40 (12.8%) |
| -8–14 days | 61 (3.8%) | 5 (1.1%) | 6 (1.9%) |
| ->14 days | 14 (0.9%) | 0 (0%) | 4 (1.3%) |
| Variants: N (%) | |||
| -Alpha | 102 (3.9%) | 23 (3.6%) | 13 (2.5%) |
| -Delta | 2517 (96.1%) | 613 (96.4%) | 507 (97.5%) |
| Nasopharyngeal viral load (log10 copies/mL) Median (IQR) |
7.1 (5.7–7.9) |
7 (5.6–7.8) |
6.6 (5.4–7.5) |